Major acquisition, new products boost Thermo Fisher earnings

By Adam Rubenfire  |  January 29, 2015

Thermo Fisher Scientific's earnings, following a major acquisition, soared 75.7% to $601.2 million in the three months ended Dec. 31. The company saw a nearly 50% jump in earnings for 2014, ending the year with $1.9 billion in net income.

Edwards Lifesciences CEO Michael Mussallem on demonstrating value, device-tax repeal

Edwards Lifesciences CEO Michael Mussallem on demonstrating value, device-tax repeal

By Modern Healthcare  |  January 24, 2015

Michael Mussallem, chairman and CEO of Irvine, Calif.-based devicemaker Edwards Lifesciences, discusses the company's plans, how his firm demonstrates the value of its products to health systems and the prospects for repeal of the medical-device tax. He spoke with Modern Healthcare reporter Jaimy...

New models send spinal cord stimulator prices up 8%

By Jaimy Lee  |  January 23, 2015

Hospitals are facing higher prices for spinal cord stimulators, used to treat patients with chronic pain, since two manufacturers launched more complex versions of the devices in 2013, according to the Modern Healthcare/ECRI Institute Technology Price Index.

Johnson & Johnson sees 28% drop in Q4 net income

By Jaimy Lee  |  January 20, 2015

Johnson & Johnson reported a 28% drop in net income and flat sales in the fourth quarter of 2014. The income falloff came about because of the impact of unfavorable currency fluctuations along with charges, including integration costs related to the 2012 acquisition of Synthes, and increased...

Are hep C exclusivity deals taking power from doctors?

Are hep C exclusivity deals taking power from doctors?

By Virgil Dickson  |  January 12, 2015

Exclusivity deals for hepatitis C drugs by pharmacy benefit managers and a major health plan have raised concerns that the decision of which drug is best for a patient is being taken away from clinicians.

Outlook 2015: Supply chain

Outlook 2015: Supply chain

By Jaimy Lee  |  January 03, 2015

Hospitals in 2015 will continue to search for ways to cut the costs of medical supplies and other nonlabor expenses while developing better methods to measure the value of clinical products.

Suit alleges Abbott, supplier Omnicare involved in illegal kickback scheme

By Lisa Schencker  |  December 22, 2014

Omnicare illegally accepted millions of dollars in kickbacks from Abbott Laboratories in exchange for pushing doctors to prescribe a specific drug to dementia patients, the government is alleging in a lawsuit filed Monday against the institutional pharmacy provider.

Modern Healthcare Daily

The top stories in healthcare business every day

The Modern Healthcare Daily News App provides you with registration-free access to the top trending healthcare business news. It's the only news you need each day.